bromodeoxyuridine has been researched along with Ambulation Disorders, Neurologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopp, M; Mahmood, A; Meng, Y; Ning, R; Qu, C; Xiong, Y; Zhang, Y | 1 |
| Chopp, M; Goussev, A; Lu, D; Mahmood, A; Qu, C; Schallert, T; Xiong, Y | 1 |
2 other study(ies) available for bromodeoxyuridine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury.
Topics: Analysis of Variance; Animals; Body Weight; Brain Injuries; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Erythropoietin; Gait Disorders, Neurologic; Male; Maze Learning; Neovascularization, Pathologic; Phosphopyruvate Hydratase; Rats; Rats, Wistar; Recovery of Function; Severity of Illness Index; von Willebrand Factor | 2011 |
Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice.
Topics: Animals; Behavior, Animal; Brain Injuries; Bromodeoxyuridine; Cell Count; Cell Proliferation; Cerebral Cortex; Dentate Gyrus; Disease Models, Animal; Erythropoietin; Female; Gait Disorders, Neurologic; Learning Disabilities; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neuroprotective Agents; Phosphopyruvate Hydratase; Recombinant Proteins; Sex Characteristics; Time Factors | 2007 |